Moreover, p53-null CAFs could be instructed to deposit mut-p53-like ECM when treated with conditioned medium (CM) derived from either mutp53 pancreatic cancer cells (PCCs) or CAFs. This evidence concerns the gene TP53 and familial pancreatic carcinoma.